Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2010 1
2011 1
2012 1
2015 1
2020 1
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats.
Stokes AH, Franklin K, Fisher DE, Posobiec LM, Binazon O, Tripathi N, Ringenberg MA, Charlap J, Ziejewski MK, Vemireddi V, Khanna Weiss P, Majumdar R, Bouzya B, Donner MN, Rodriguez LA, Baumeister J. Stokes AH, et al. Among authors: baumeister j. Int J Toxicol. 2021 Mar-Apr;40(2):125-142. doi: 10.1177/1091581820985782. Epub 2021 Feb 1. Int J Toxicol. 2021. PMID: 33517807
Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbits.
Destexhe É, Grosdidier É, Bouhraoua A, Thirion-Delalande C, Bouzya B, Rouxel RN, Mallett CP, Baumeister J. Destexhe É, et al. Among authors: baumeister j. Regul Toxicol Pharmacol. 2020 Jun;113:104625. doi: 10.1016/j.yrtph.2020.104625. Epub 2020 Feb 28. Regul Toxicol Pharmacol. 2020. PMID: 32119974
Repeated-Dose Toxicity, Biodistribution, and Shedding Assessments With a ChAd155 Respiratory Syncytial Virus Vaccine Candidate Evaluated in Rabbits and Rats.
Stokes AH, Planty C, Pion J, Ancian P, Rogue A, Bansard C, Silvano J, Papineau D, Ben Abdeljelil N, Maruggi G, Song H, Spickler C, Blouin K, Dubois G, Rodriguez LA, Baumeister J, Steff AM, Destexhe E. Stokes AH, et al. Among authors: baumeister j. Int J Toxicol. 2022 Aug;41(4):263-275. doi: 10.1177/10915818221101788. Epub 2022 Jun 2. Int J Toxicol. 2022. PMID: 35653115
In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.
Lischka P, Hewlett G, Wunberg T, Baumeister J, Paulsen D, Goldner T, Ruebsamen-Schaeff H, Zimmermann H. Lischka P, et al. Among authors: baumeister j. Antimicrob Agents Chemother. 2010 Mar;54(3):1290-7. doi: 10.1128/AAC.01596-09. Epub 2010 Jan 4. Antimicrob Agents Chemother. 2010. PMID: 20047911 Free PMC article.
New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.
Kleymann G, Fischer R, Betz UA, Hendrix M, Bender W, Schneider U, Handke G, Eckenberg P, Hewlett G, Pevzner V, Baumeister J, Weber O, Henninger K, Keldenich J, Jensen A, Kolb J, Bach U, Popp A, Mäben J, Frappa I, Haebich D, Lockhoff O, Rübsamen-Waigmann H. Kleymann G, et al. Among authors: baumeister j. Nat Med. 2002 Apr;8(4):392-8. doi: 10.1038/nm0402-392. Nat Med. 2002. PMID: 11927946
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs.
Ulrichts H, Silence K, Schoolmeester A, de Jaegere P, Rossenu S, Roodt J, Priem S, Lauwereys M, Casteels P, Van Bockstaele F, Verschueren K, Stanssens P, Baumeister J, Holz JB. Ulrichts H, et al. Among authors: baumeister j. Blood. 2011 Jul 21;118(3):757-65. doi: 10.1182/blood-2010-11-317859. Epub 2011 May 16. Blood. 2011. PMID: 21576702 Free article.
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis.
Van Roy M, Ververken C, Beirnaert E, Hoefman S, Kolkman J, Vierboom M, Breedveld E, 't Hart B, Poelmans S, Bontinck L, Hemeryck A, Jacobs S, Baumeister J, Ulrichts H. Van Roy M, et al. Among authors: baumeister j. Arthritis Res Ther. 2015 May 20;17(1):135. doi: 10.1186/s13075-015-0651-0. Arthritis Res Ther. 2015. PMID: 25994180 Free PMC article.